Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 380

1.

Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus.

Malenica M, Šilar M, Dujić T, Bego T, Semiz S, Škrbo S, Prnjavorac B, Čaušević A.

Med Glas (Zenica). 2017 Aug 1;14(2):169-175. doi: 10.17392/920-17.

2.

Autoantibodies Against PFDN2 Are Associated With An Increased Risk of Type 2 Diabetes: A Case-Control Study.

Chang DC, Piaggi P, Hanson RL, Knowler WC, Bogardus C, Krakoff J.

Diabetes Metab Res Rev. 2017 Jul 21. doi: 10.1002/dmrr.2922. [Epub ahead of print]

PMID:
28731290
3.

Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study.

Čabarkapa V, Ilinčić B, Đerić M, Radosavkić I, Šipovac M, Sudji J, Petrović V.

J Med Biochem. 2017 Apr 22;36(2):153-162. doi: 10.1515/jomb-2017-0006. eCollection 2017 Apr.

4.

Chronic Glibenclamide Treatment Attenuates Walker-256 Tumour Growth in Prediabetic Obese Rats.

da Silva Franco CC, Previate C, de Barros Machado KG, Piovan S, Miranda RA, Prates KV, Moreira VM, de Oliveira JC, Barella LF, Gomes RM, Francisco FA, Martins IP, Pavanello A, Ribeiro TA, Tófolo LP, Malta A, de Souza AA, Alves VS, da Silva Silveira S, Marçal Natali MR, Fernando Besson JC, de Morais H, de Souza HM, de Sant Anna JR, Alves de Castro Prado MA, de Freitas Mathias PC.

Cell Physiol Biochem. 2017;42(1):81-90. doi: 10.1159/000477117. Epub 2017 May 11.

5.

Increased urine acylcarnitines in diabetic ApoE-/- mice: Hydroxytetradecadienoylcarnitine (C14:2-OH) reflects diabetic nephropathy in a context of hyperlipidemia.

Mirzoyan K, Klavins K, Koal T, Gillet M, Marsal D, Denis C, Klein J, Bascands JL, Schanstra JP, Saulnier-Blache JS.

Biochem Biophys Res Commun. 2017 May 20;487(1):109-115. doi: 10.1016/j.bbrc.2017.04.026. Epub 2017 Apr 7.

PMID:
28396151
6.

Teneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy.

Abubaker M, Mishra P, Swami OC.

J Clin Diagn Res. 2017 Jan;11(1):OE05-OE09. doi: 10.7860/JCDR/2017/25060.9228. Epub 2017 Jan 1. Review.

7.

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes.

Messana JA, Schwartz SS, Townsend RR.

Vasc Health Risk Manag. 2017 Feb 17;13:43-54. doi: 10.2147/VHRM.S105721. eCollection 2017. Review.

8.

Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats.

Abo El Gheit R, Emam MN.

Physiol Int. 2016 Dec;103(4):413-427. doi: 10.1556/2060.103.2016.4.001.

PMID:
28229631
9.

The Efficacy of a Prevascularized, Retrievable Poly(D,L,-lactide-co-ε-caprolactone) Subcutaneous Scaffold as Transplantation Site for Pancreatic Islets.

Smink AM, Li S, Hertsig DT, de Haan BJ, Schwab L, van Apeldoorn AA, de Koning E, Faas MM, Lakey JR, de Vos P.

Transplantation. 2017 Apr;101(4):e112-e119. doi: 10.1097/TP.0000000000001663.

PMID:
28207637
10.

Nanoparticle formulation increases Syzygium cumini antioxidant activity in Candida albicans-infected diabetic rats.

Bitencourt PE, Cargnelutti LO, Stein CS, Lautenchleger R, Ferreira LM, Sangoi M, Denardi L, Borges RM, Boligon A, Moresco RN, Cruz L, Zanette RA, Alves SH, Moretto MB.

Pharm Biol. 2017 Dec;55(1):1082-1088. doi: 10.1080/13880209.2017.1283338.

PMID:
28193098
11.

Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling.

Antony PJ, Gandhi GR, Stalin A, Balakrishna K, Toppo E, Sivasankaran K, Ignacimuthu S, Al-Dhabi NA.

Biomed Pharmacother. 2017 Apr;88:1098-1113. doi: 10.1016/j.biopha.2017.01.170. Epub 2017 Feb 10.

PMID:
28192884
12.

Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes.

Ziamajidi N, Nasiri A, Abbasalipourkabir R, Sadeghi Moheb S.

Pharm Biol. 2017 Dec;55(1):526-531.

PMID:
27937047
14.

Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.

Reed JW.

Vasc Health Risk Manag. 2016 Oct 27;12:393-405. eCollection 2016. Review.

15.

How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake.

Polidori D, Sanghvi A, Seeley RJ, Hall KD.

Obesity (Silver Spring). 2016 Nov;24(11):2289-2295. doi: 10.1002/oby.21653.

PMID:
27804272
16.

[Evaluation of markers for renal graft dysfunction in patients with type 1 diabetes mellitus after kidney transplantation and simultaneous pancreas-kidney transplantation].

Glazunova AM, Arutyunova MS, Tarasov EV, Nikankina LV, Ilyin AV, Shamkhalova MS, Shestakova MV, Moysyuk YG.

Ter Arkh. 2016;88(10):25-34. doi: 10.17116/terarkh2016881025-34. Russian.

PMID:
27801416
17.

Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors.

Rizzi M, Trevisan R.

Nutr Metab Cardiovasc Dis. 2016 Nov;26(11):963-970. doi: 10.1016/j.numecd.2016.07.006. Epub 2016 Jul 12. Review.

PMID:
27514605
18.

Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.

Hamza AH, Al-Bishri WM, Damiati LA, Ahmed HH.

Ren Fail. 2017 Nov;39(1):67-76. doi: 10.1080/0886022X.2016.1244080. Epub 2016 Oct 23.

PMID:
27774826
19.

Rice endosperm protein slows progression of fatty liver and diabetic nephropathy in Zucker diabetic fatty rats.

Kubota M, Watanabe R, Yamaguchi M, Hosojima M, Saito A, Fujii M, Fujimura S, Kadowaki M.

Br J Nutr. 2016 Oct;116(8):1326-1335. Epub 2016 Oct 11.

PMID:
27724997
20.

In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.

Sampath C, Sang S, Ahmedna M.

Biomed Pharmacother. 2016 Dec;84:502-513. doi: 10.1016/j.biopha.2016.09.073. Epub 2016 Sep 28.

PMID:
27685794

Supplemental Content

Loading ...
Support Center